Legend Biotech· @LegendBiotech · X·· 20 天前AI 评分18
AI 导读
#SOHO2026 现场直播 #CARTITUDE4 数据正在帮助我们加深对CAR-T输注前疾病控制的理解，包括对桥接治疗的反应。 关键结论？更深入地了解桥接治疗在标危和高危细胞遗传学患者中的作用。 在 #SOHO2026 现场？欢迎莅临 #125 展位，与传奇生物团队交流并了解更多。 #LegendBiotech #CellTherapy
正文
Live from #SOHO2026
#CARTITUDE4 data are helping deepen our understanding of disease control before CAR-T infusion, including response to bridging therapy.
The key takeaway? Greater insight into the role of bridging therapy in patients with standard-risk and high-risk cytogenetics.
Here at #SOHO2026? Stop by Booth #125 to connect with the Legend Biotech team and learn more.
#LegendBiotech #CellTherapy
来源：Legend Biotech · x.com